CFO tran­si­tion on the hori­zon at BioN­Tech as Sierk Po­et­ting con­cen­trates on COO du­ties; Centes­sa rides a wave of new ex­ecs af­ter An­toine Yver's ap­point­ment

→ As its Covid-19 vac­cine with Pfiz­er con­tin­ues to in­oc­u­late mil­lions, BioN­Tech is chang­ing CFOs be­gin­ning Ju­ly 1 with Jens Hol­stein step­ping in­to the role pre­vi­ous­ly oc­cu­pied by Sierk Po­et­ting, who will di­rect his full at­ten­tion to his work as COO mov­ing for­ward. Hol­stein was CFO at Mor­phoSys from 2011-20 and held a num­ber of lead­er­ship roles with­in the Fre­se­nius uni­verse be­fore that time.

Po­et­ting has seen BioTech turn in­to a house­hold name since his tenure be­gan in 2014, and he’s been a cru­cial voice on the vac­cine dis­tri­b­u­tion ef­forts, in­di­cat­ing some weeks ago that BioN­Tech has held dis­cus­sions on ramp­ing up ca­pac­i­ty. “There is still room for im­prove­ment. But that will ul­ti­mate­ly al­so de­pend on de­mand,” Po­et­ting told Reuters in late April.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER